• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正电子发射断层扫描在儿科神经退行性疾病中的应用。

Positron Emission Tomography in Pediatric Neurodegenerative Disorders.

机构信息

Department of Neurology, NYU School of Medicine, New York, New York.

出版信息

Pediatr Neurol. 2019 Nov;100:12-25. doi: 10.1016/j.pediatrneurol.2019.07.003. Epub 2019 Jul 17.

DOI:10.1016/j.pediatrneurol.2019.07.003
PMID:31416725
Abstract

Application of molecular neuroimaging using positron emission tomographic techniques to assess pediatric neurodegenerative disorders has been limited, unlike in adults where positron emission tomography has contributed to clinical diagnosis, monitoring of neurodegenerative disease progression, and assessment of novel therapeutic approaches. Yet, there is a huge unexplored potential of molecular imaging to improve our understanding of the pathophysiology of neurodegenerative disorders in children and provide radiological biomarkers that can be applied clinically. The obstacles in performing PET scans on children include sedation, radiation exposure, and access but, as will be illustrated, these barriers can be easily overcome. This review summarizes findings from PET studies that have been performed over the past three decades on children with various neurodegenerative disorders, including the neuronal ceroid lipofuscinoses, juvenile Huntington disease, Wilson disease, Niemann-Pick disease type C, Dravet syndrome, dystonia, mitochondrial disorders, inborn errors of metabolism, lysosomal storage diseases, dysmyelinating disorders, Rett syndrome, neurotransmitter disorders, glucose transporter Glut 1 deficiency, and Lesch-Nyhan disease. Because positron emission tomographic scans have often been clinically useful and have contributed to the management of these disorders, we suggest that the time has come for glucose metabolism positron emission tomographic scans to be reimbursed by insurance carriers for children with neurodegenerative disorders, and not restricted only to epilepsy surgery evaluation.

摘要

应用正电子发射断层扫描技术进行分子神经影像学检查来评估儿科神经退行性疾病的应用一直受到限制,而在成人中,正电子发射断层扫描有助于临床诊断、监测神经退行性疾病的进展,并评估新的治疗方法。然而,分子成像具有巨大的尚未开发的潜力,可以帮助我们更好地了解儿童神经退行性疾病的病理生理学,并提供可应用于临床的放射学生物标志物。在儿童中进行正电子发射断层扫描的障碍包括镇静、辐射暴露和获取,但正如将说明的那样,这些障碍可以很容易地克服。这篇综述总结了过去三十年在患有各种神经退行性疾病的儿童中进行的正电子发射断层扫描研究结果,包括神经元蜡样质脂褐质沉积症、青少年亨廷顿病、威尔逊病、尼曼-皮克病 C 型、Dravet 综合征、肌张力障碍、线粒体疾病、先天性代谢缺陷、溶酶体贮积病、脱髓鞘疾病、雷特综合征、神经递质疾病、葡萄糖转运蛋白 Glut1 缺乏症和 Lesch-Nyhan 病。由于正电子发射断层扫描检查在临床上通常是有用的,并有助于这些疾病的治疗,因此我们建议,现在是时候让保险公司为患有神经退行性疾病的儿童报销葡萄糖代谢正电子发射断层扫描检查费用,而不仅仅限于癫痫手术评估。

相似文献

1
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.正电子发射断层扫描在儿科神经退行性疾病中的应用。
Pediatr Neurol. 2019 Nov;100:12-25. doi: 10.1016/j.pediatrneurol.2019.07.003. Epub 2019 Jul 17.
2
In vivo tomographic imaging studies of neurodegeneration and neuroprotection: a review.神经退行性变与神经保护的体内断层成像研究:综述
Methods Mol Biol. 2007;399:215-33. doi: 10.1007/978-1-59745-504-6_15.
3
Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases.18 kDa转位蛋白(TSPO)正电子发射断层扫描(PET)成像及其在神经退行性疾病中的临床影响
Int J Mol Sci. 2017 Apr 7;18(4):785. doi: 10.3390/ijms18040785.
4
Update on PET in neurodegenerative and neuroinflammatory disorders manifesting on a behavioural level: imaging for differential diagnosis.神经退行性和神经炎性疾病在行为层面上的 PET 研究进展:用于鉴别诊断的影像学检查。
Curr Opin Neurol. 2019 Aug;32(4):548-556. doi: 10.1097/WCO.0000000000000706.
5
Target-specific PET probes for neurodegenerative disorders related to dementia.针对与痴呆相关的神经退行性疾病的靶向性 PET 探针。
J Nucl Med. 2010 Sep;51(9):1418-30. doi: 10.2967/jnumed.110.077164.
6
New molecular targets for PET and SPECT imaging in neurodegenerative diseases.用于神经退行性疾病的 PET 和 SPECT 成像的新分子靶标。
Braz J Psychiatry. 2012 Oct;34 Suppl 2:S125-36. doi: 10.1016/j.rbp.2012.07.002.
7
PET Molecular Imaging in Atypical Parkinsonism.正电子发射断层扫描分子影像学在非典型帕金森病中的应用。
Int Rev Neurobiol. 2018;142:3-36. doi: 10.1016/bs.irn.2018.09.001. Epub 2018 Oct 8.
8
Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias.磁共振成像和正电子发射断层扫描在神经退行性痴呆诊断中的应用
Funct Neurol. 2016 Oct/Dec;31(4):205-215. doi: 10.11138/fneur/2016.31.4.205.
9
Imaging of neurodegenerative cognitive and behavioral disorders: practical considerations for dementia clinical practice.神经退行性认知和行为障碍的影像学检查:痴呆临床实践的实际考量
Handb Clin Neurol. 2016;136:971-84. doi: 10.1016/B978-0-444-53486-6.00050-8.
10
Novel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases.新型 PET 生物标志物可厘清与年龄相关的神经退行性疾病中的分子途径。
Cells. 2020 Dec 2;9(12):2581. doi: 10.3390/cells9122581.

引用本文的文献

1
Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot Study.脆性X综合征男性患者中脆性X智力低下蛋白与代谢型谷氨酸受体5亚型的脑内表达:一项初步研究
Brain Sci. 2022 Feb 26;12(3):314. doi: 10.3390/brainsci12030314.
2
Multimodal Neuroimaging in Rett Syndrome With Mutation.伴有突变的雷特综合征的多模态神经影像学
Front Neurol. 2022 Feb 23;13:838206. doi: 10.3389/fneur.2022.838206. eCollection 2022.
3
Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients.
CLN2 病患者的诊断、临床评估、治疗和管理指南。
Orphanet J Rare Dis. 2021 Apr 21;16(1):185. doi: 10.1186/s13023-021-01813-5.
4
Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study.特发性自闭症谱系障碍和脆性 X 综合征中代谢型谷氨酸受体亚型 5 的脑表达:一项初步研究。
Int J Mol Sci. 2021 Mar 11;22(6):2863. doi: 10.3390/ijms22062863.
5
Huntington's Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers.亨廷顿病:已知正电子发射断层扫描成像生物标志物和靶向放射性示踪剂的综述。
Molecules. 2020 Jan 23;25(3):482. doi: 10.3390/molecules25030482.